CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Learn effective ways to make fast cash while working from home. These tips can help you enhance your income quickly.
28,086 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
What makes a dividend stock truly worth holding forever? This guide dives into two magnificent dividend stocks worth ...
As markets wobble in mid-2026, a trio of NYSE dividend names stands out for safety and income. They combine durable c...
Got $10,000 and a goal to generate reliable cash from dividends? This guide shows how to pick the smartest dividend s...
A trio of monthly-paying funds could steady-cash a $100,000 portfolio to about $750 a month, aiming for $9,000 in ann...
Block announces a sweeping AI-driven overhaul, cutting staff by more than 4,000 and reorganizing around a leaner oper...
As markets brace for a mid-month catalyst, March 16 could be a pivotal moment. This guide breaks down the drivers, sc...
Craving AI gains but wary of pitfalls? This guide shows how to diversify portfolio 2026 by steering clear of two risk...
Berkshire Hathaway sits on a massive stock portfolio and a mountain of cash. As leadership quietly shifts, investors ...
A thorough look at Novanta's Q1 2026 results and what they signal for novanta (novt) 2026 earnings. We break down rev...
In a volatile rate environment, energy stocks secretly better than Treasuries are drawing income-focused investors to...
No investment guarantees 100% success through every recession. But some options have repeatedly shown resilience. Thi...